» Articles » PMID: 23861821

MicroRNA-196b Regulates the Homeobox B7-vascular Endothelial Growth Factor Axis in Cervical Cancer

Overview
Journal PLoS One
Date 2013 Jul 18
PMID 23861821
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The down-regulation of microRNA-196b (miR-196b) has been reported, but its contribution to cervical cancer progression remains to be investigated. In this study, we first demonstrated that miR-196b down-regulation was significantly associated with worse disease-free survival (DFS) for cervical cancer patients treated with combined chemo-radiation. Secondly, using a tri-modal approach for target identification, we determined that homeobox-B7 (HOXB7) was a bona fide target for miR-196b, and in turn, vascular endothelial growth factor (VEGF) was a downstream transcript regulated by HOXB7. Reconstitution of miR-196b expression by transient transfection resulted in reduced cell growth, clonogenicity, migration and invasion in vitro, as well as reduced tumor angiogenesis and tumor cell proliferation in vivo. Concordantly, siRNA knockdown of HOXB7 or VEGF phenocopied the biological effects of miR-196b over-expression. Our findings have demonstrated that the miR-196b/HOXB7/VEGF pathway plays an important role in cervical cancer progression; hence targeting this pathway could be a promising therapeutic strategy for the future management of this disease.

Citing Articles

A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.

Wang S, Zhang S Reprod Sci. 2023; 31(2):514-531.

PMID: 37749448 DOI: 10.1007/s43032-023-01364-z.


METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b.

Huang L, Liang D, Zhang Y, Chen X, Chen J, Wen C J Cancer Res Clin Oncol. 2022; 149(8):5095-5108.

PMID: 36348020 PMC: 10349789. DOI: 10.1007/s00432-022-04429-9.


The analysis of tumor-infiltrating immune cell and ceRNA networks in laryngeal squamous cell carcinoma.

Li D, Dong K, Su J, Xue H, Tian J, Wu Y Medicine (Baltimore). 2022; 101(31):e29555.

PMID: 35945754 PMC: 9351901. DOI: 10.1097/MD.0000000000029555.


Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer.

Parashar D, Singh A, Gupta S, Sharma A, Sharma M, Roy K Genes (Basel). 2022; 13(7).

PMID: 35886037 PMC: 9317009. DOI: 10.3390/genes13071254.


Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.

Morgan R, Hunter K, Pandha H Int J Cancer. 2022; 150(12):1919-1932.

PMID: 35080776 PMC: 9304284. DOI: 10.1002/ijc.33949.


References
1.
Hui A, Bruce J, Alajez N, Shi W, Yue S, Perez-Ordonez B . Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res. 2011; 17(24):7539-50. DOI: 10.1158/1078-0432.CCR-11-2102. View

2.
Hui A, Shi W, Boutros P, Miller N, Pintilie M, Fyles T . Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest. 2009; 89(5):597-606. DOI: 10.1038/labinvest.2009.12. View

3.
Cillo C, Schiavo G, Cantile M, Bihl M, Sorrentino P, Carafa V . The HOX gene network in hepatocellular carcinoma. Int J Cancer. 2011; 129(11):2577-87. DOI: 10.1002/ijc.25941. View

4.
Shah N, Sukumar S . The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010; 10(5):361-71. DOI: 10.1038/nrc2826. View

5.
Bentwich I . Prediction and validation of microRNAs and their targets. FEBS Lett. 2005; 579(26):5904-10. DOI: 10.1016/j.febslet.2005.09.040. View